XENE
Xenon Pharmaceuticals Inc Earnings
$35.09
Earnings Summary
Revenue | $0Mn |
Net Profits | $-65.69Mn |
Net Profit Margins | -Inf% |
Xenon Pharmaceuticals Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated NaN% jump in its revenue since last 3-months.
Xenon Pharmaceuticals Inc’s net profit fell -46.81% since last year same period to $-65.69Mn in the Q4 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated -4.61% fall in its net profits since last 3-months.
Xenon Pharmaceuticals Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.84 |
EPS Estimate Current Year | -0.84 |
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.84 - a -3.6% fall from last quarter’s estimates.
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.84.
Key Ratios
Earning Per Share (EPS) | -0.84 |
Xenon Pharmaceuticals Inc’s earning per share (EPS) fell -31.25% since last year same period to -0.84 in the Q4 2024. This indicates that the Xenon Pharmaceuticals Inc has generated -31.25% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-08 | -0.7 | -0.75 | -7.14% |
2025-02-27 | -0.84 | -0.84 | -0.1% |
2024-05-09 | -0.66 | -0.62 | 6.06% |
2024-11-12 | -0.81 | -0.81 | 0% |
